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  Activity of urinary N－acetyl－B－D－giucosaminidase （u－NAG） has been studied in patients with
urological renal diseases and in renal allograft recipients． Elevation of u－NAG was more marked
after nephrolithotomy co皿pared to the elevation after pyeloplasty or pyelolithotomy． Increased
u－NAG level was highest on about the 7th postoperative day and decreased gradually to within the
normal range． The elevation of u－NAG correlated to the degree of renal damage． Hydronephrosis
after ureteroneovesicostomy was accompanied by an elevated u－NAG level which was normalized
after re－mission of hydronephrosis． ln renal transplant recipients the elevation of u－NAG preceeded
the clinical diagnosis of acute rejection， and was thought to be of diagnostic value． Urinary NAG
assay is simple and considered to be a usefu1 aid in the follow－up examination after urologic renal
surgery as an indicator of renal damage．





















































      Urine Sample O． t ml
           ・
O．1 5M Citrate－Phospha’狽?Buffer PH4．8 t．Oml
           J＊
     1 OmM 4－MethylumbelliferyL－
   N－AcetyL－13－D－Glucosaminide O． 1 mt
           ，
        lncubated for
        l hr at 37’C
           ・
O． 1 7M Glycine－Carbonite Buffer PH99 3．Oml
           ・
       Ftuorimetry
         Exoitation 365nm
         Emission 450nm
 B Form
  ＊ Sncubated for 2 hrs at 50“C
 A Form＝Totat－B Form































   丁otal A  B
Mean 25．5 17．1 8．5
SD 11．5 7．6 5．4
    0verali
    n ＝26
   Age 3－43
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Fig． 3． Changes of urinary NAG after
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Fig． 5． Changes of urinary NAG after contralateral nephrectomy
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  〈M± SE）
NAG excretion fro皿hydronephrotickidney after ureteroneovesicostomy















































    AHLG ［言oo－Fig． 9． Postoperative course and urinary    NAG change in one case with renal
    allograft
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